Shuling Han

1.3k total citations · 1 hit paper
28 papers, 346 citations indexed

About

Shuling Han is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Shuling Han has authored 28 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Shuling Han's work include Cancer Immunotherapy and Biomarkers (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Immune Cell Function and Interaction (3 papers). Shuling Han is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Immune Cell Function and Interaction (3 papers). Shuling Han collaborates with scholars based in China, United States and Canada. Shuling Han's co-authors include Yanqiao Zhang, Lin Fang, Chunhui Zhang, Chao Liu, Xin Guan, Bojun Wang, Fei Zhan, Haoxiu Sun, Yuanfei Yao and Tongsen Zheng and has published in prestigious journals such as PLoS ONE, Circulation Research and Cancer Research.

In The Last Decade

Shuling Han

23 papers receiving 343 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer

2021 170 citations Chao Liu, Ruiqi Liu et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuling Han China	8	183	110	98	52	50	28	346
Sara A. Väyrynen Finland	11	233 1.3×	99 0.9×	93 0.9×	62 1.2×	49 1.0×	17	408
Daqian Gu China	7	119 0.7×	100 0.9×	82 0.8×	35 0.7×	21 0.4×	8	298
Tetsuro Kawazoe Japan	6	155 0.8×	46 0.4×	98 1.0×	67 1.3×	49 1.0×	22	295
Zi‐Niu Ding China	11	179 1.0×	68 0.6×	72 0.7×	75 1.4×	38 0.8×	45	391
Shaolong Sun China	10	132 0.7×	41 0.4×	155 1.6×	48 0.9×	70 1.4×	21	331
Satoshi Tamauchi Japan	12	147 0.8×	93 0.8×	119 1.2×	81 1.6×	88 1.8×	67	589
Shinobu Tomochika Japan	9	125 0.7×	51 0.5×	56 0.6×	72 1.4×	108 2.2×	39	285
Yingying Huang China	9	106 0.6×	48 0.4×	106 1.1×	39 0.8×	42 0.8×	30	326
Haijie Hong China	14	128 0.7×	67 0.6×	152 1.6×	128 2.5×	128 2.6×	26	410

Countries citing papers authored by Shuling Han

Since Specialization

Citations

This map shows the geographic impact of Shuling Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuling Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuling Han more than expected).

Fields of papers citing papers by Shuling Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuling Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuling Han. The network helps show where Shuling Han may publish in the future.

Co-authorship network of co-authors of Shuling Han

This figure shows the co-authorship network connecting the top 25 collaborators of Shuling Han. A scholar is included among the top collaborators of Shuling Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuling Han. Shuling Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Shuling, Chang Hong, Xin Guan, et al.. (2025). USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment. Cancer Immunology Research. 13(8). 1226–1245. 2 indexed citations

Wu, Tong, Lin Fang, Dan Su, et al.. (2025). Tumor aggression-defense index–a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer. Journal of Translational Medicine. 23(1). 107–107. 2 indexed citations

DeBerge, Matthew, Connor Lantz, Zhi‐Dong Ge, et al.. (2025). Mechanical regulation of macrophage metabolism by allograft inflammatory factor 1 leads to adverse remodeling after cardiac injury. Nature Cardiovascular Research. 4(1). 83–101. 3 indexed citations

Han, Shuling, et al.. (2025). Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response. Cancer Letters. 631. 217946–217946.

Zhang, Lei, Shuling Han, Olivia M. Martinez, & Sheri M. Krams. (2025). SENP2 as a critical regulator in liver ischemia-reperfusion injury. The International Journal of Biochemistry & Cell Biology. 180. 106741–106741.

Tajima, Tetsuya, Wenming Zhang, Shuling Han, et al.. (2025). IL-17A-producing γδ T cells and classical monocytes are associated with a rapid alloimmune response following vascularized composite allotransplantation in mice. Frontiers in Immunology. 16. 1584916–1584916. 1 indexed citations

Wang, Bojun, Shuling Han, Xin Guan, et al.. (2025). Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer. Cell Reports Medicine. 6(12). 102480–102480.

Han, Shuling, Jiao-Jing Wang, Craig Weiss, et al.. (2025). Revealing gait as a murine biomarker of injury, disease, and age with multivariate statistics and machine learning. Scientific Reports. 15(1). 33457–33457.

Han, Shuling, et al.. (2024). Graft-derived extracellular vesicles transport miRNAs to modulate macrophage polarization after heart transplantation. American Journal of Transplantation. 25(4). 682–694. 2 indexed citations

10.

Liu, Ruiqi, Shuling Han, Chunhui Zhang, et al.. (2024). Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer. Cancer Research. 85(5). 925–941. 12 indexed citations

11.

Yang, Rui, Bojun Wang, Luying Cui, et al.. (2024). Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer. Oncogene. 44(14). 944–957. 5 indexed citations

12.

Liu, Chao, Rui Huang, Lin Fang, et al.. (2024). Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study. Cancer Immunology Immunotherapy. 73(8). 159–159. 1 indexed citations

13.

Fang, Lin, Yang Yao, Xin Guan, et al.. (2023). China special issue on gastrointestinal tumors‐Regulatory‐immunoscore—A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer. International Journal of Cancer. 153(11). 1904–1915. 6 indexed citations

14.

Yao, Yang, Chao Liu, Bojun Wang, et al.. (2022). HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis. Cancer Letters. 533. 215595–215595. 30 indexed citations

15.

Liu, Chao, Luying Cui, Lin Fang, et al.. (2022). Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer. Frontiers in Immunology. 13. 1039631–1039631. 3 indexed citations

16.

Liu, Chao, Ruiqi Liu, Bojun Wang, et al.. (2021). Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. Journal for ImmunoTherapy of Cancer. 9(1). e001895–e001895. 170 indexed citations breakdown →

17.

Fang, Lin, Chao Liu, Jing Chen, et al.. (2020). Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer. Cancer Research and Treatment. 53(1). 131–139. 56 indexed citations

18.

Han, Shuling, Shiyue Xu, Junlan Zhou, et al.. (2019). Sam68 impedes the recovery of arterial injury by augmenting inflammatory response. Journal of Molecular and Cellular Cardiology. 137. 82–92. 12 indexed citations

19.

Rowley, Anne H., Susan C. Baker, Kwang‐Youn A. Kim, et al.. (2017). Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis. Journal of the Pediatric Infectious Diseases Society. 6(3). e94–e102. 10 indexed citations

20.

Zhou, Junlan, Min Cheng, Chan Boriboun, et al.. (2015). Inhibition of Sam68 triggers adipose tissue browning. Journal of Endocrinology. 225(3). 181–189. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact